VIVO 16.19 Meridian Bioscience Inc $VIVO Hit a 52 week low

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
VIVO 16.19 Meridian Bioscience Inc $VIVO Hit a 52 week low of 16.12 Closing the day 10:45 at 16.19 unch unch With a day low of 16.12 and a total volume of 22,944.

VIVO Recent Posts: http://investorshangout.com/Meridian-Bioscien...IVO-55809/

VIVO Meridian Bioscience Inc Recent Headline News

Healthcare's Top Dividend Paying Stocks
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 13, 6:43AM CST
Source: Flickr user TaxRebate.org.uk. Dividends are the foundation to which all great long-term portfolio are built. Receiving a payment equal to 2% or 3% per year might not seem like much, but reinvested into that same growing company over the...
VIVO: 16.15 (-0.04), PETS: 13.60 (-0.01), GSK: 45.85 (+0.11), SNY: 47.29 (+0.61), PDLI: 7.93 (+0.14)

Meridian Bioscience (VIVO) Misses Q4 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:20AM CST
Meridian Bioscience Inc. (VIVO) reported fourth-quarter fiscal 2014 earnings of 20 cents per share, which missed the Zacks Consensus Estimate by a couple of cents
BSX: 13.39 (+0.03), VIVO: 16.15 (-0.04), ABAX: 55.00 (+0.20), OSUR: 8.80 (+0.03)

Meridian Bioscience Down 13.7% Since SmarTrend Downtrend Call (VIVO)
Comtex SmarTrend(R) - Mon Nov 10, 9:45AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 3 months, Meridian Bioscience has returned 13.75% as of today's recent price of $16.91.
VIVO: 16.15 (-0.04)

Meridian Bioscience (VIVO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:55AM CST
Meridian Bioscience saw a big move last session, as the company’s shares fell by nearly 6% which continued the recent downtrend
VIVO: 16.15 (-0.04), ABAX: 55.00 (+0.20), GWPH: 75.22 (-0.41), OSUR: 8.80 (+0.03)

Downgrade Alert for Meridian Bioscience (VIVO)
Comtex SmarTrend(R) - Fri Nov 07, 6:59AM CST
Meridian Bioscience (NASDAQ:VIVO) was downgraded from Outperform to Neutral at RW Baird today. The stock closed yesterday at $17.91 on volume of 374,000 shares, above average daily volume of 203,000. Over the past year, Meridian Bioscience has traded in a range of $17.12 to $27.72 and closed yesterday at $17.91, 5% above that low. The 200-day and 50-day moving averages have moved 0.73% lower and 0.51% lower over the past week, respectively.
VIVO: 16.15 (-0.04)

Meridian Bioscience misses Street 4Q forecasts
Automated Insights - Thu Nov 06, 10:18AM CST
CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Thursday reported fiscal fourth-quarter net income of $8.2 million.
VIVO: 16.15 (-0.04)

Meridian Bioscience declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 7:55AM CST

VIVO: 16.15 (-0.04)

Meridian Bioscience misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 7:02AM CST

VIVO: 16.15 (-0.04)

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
Business Wire - Thu Nov 06, 6:30AM CST
Meridian Bioscience, Inc. (NASDAQ: VIVO):
VIVO: 16.15 (-0.04)

7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST

KND: 19.38 (-0.54), VIVO: 16.15 (-0.04), PETS: 13.60 (-0.01), PFE: 29.95 (-0.39), GSK: 45.86 (+0.12), MR: 31.24 (+0.18), SEM: 13.58 (-0.21), PDLI: 7.93 (+0.14), SNN: 33.55 (+0.28), AZN: 72.13 (-0.72), MRK: 59.73 (+0.66), STJ: 64.85 (-0.14), TRIB: 17.12 (-0.01), ABBV: 64.99 (+0.99), THRX: 13.19 (-0.04), SNY: 47.29 (+0.61)

Meridian Bioscience Down 9.6% Since SmarTrend Downtrend Call (VIVO)
Comtex SmarTrend(R) - Thu Oct 23, 9:58AM CDT
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 2 months, Meridian Bioscience has returned 9.61% as of today's recent price of $17.72.
VIVO: 16.15 (-0.04)

Meridian Bioscience Offers Testing Solutions to Premier - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 12:50PM CDT
The illumigene molecular system uses loop-mediated isothermal DNA amplification technology, which is an efficient system to allow Meridian Bioscience (VIVO) to provide customers the illumipro 10 instrument without a capital investment or costly annual service contract.
ICUI: 86.47 (+0.76), SMA: 9.48 (+0.04), VIVO: 16.15 (-0.04), ABAX: 55.00 (+0.20)

Meridian Bioscience's Earnings Outlook Show Flat Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 12:40PM CDT
Meridian Bioscience (VIVO) also expects net revenues to grow in the range of 2 to 5% to approximately between $193 and $200 million for fiscal 2015.
ICUI: 86.47 (+0.76), SMA: 9.48 (+0.04), VIVO: 16.15 (-0.04), ABAX: 55.00 (+0.20)

Meridian Bioscience Signs Agreement with Premier, Inc. to Offer Its Hospitals Molecular Diagnostic Tests and Instruments for C. difficile, Group B Streptococcus, Group A Streptococcus, Bordetella pertussis, and Mycoplasma pneumoniae
Business Wire - Wed Sep 03, 6:30AM CDT
Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene(R) molecular menu of tests to its members. Premier serves more than 3,000 U.S. hospitals and 110,000-plus other healthcare sites. This agreement offers each Premier healthcare facility the opportunity to implement rapid, sensitive, molecular tests for C. difficile, Group B Streptococcus, Group A Streptococcus, Bordetella pertussis, and Mycoplasma pneumoniae on the illumigene molecular platform without individual negotiations.
VIVO: 16.15 (-0.04), PINC: 33.39 (+0.34)

Meridian Bioscience Provides Net Revenues and Earnings Guidance for Fiscal 2015 and Reaffirms Fiscal 2014 Guidance
Business Wire - Tue Sep 02, 6:30AM CDT
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company's fiscal 2015 sales and earnings estimates. Based on the Company's business planning and budgeting activities for the fiscal year ending September 30, 2015, management expects net revenues to be in the range of $193 to $200 million, or 2% to 5% growth, and per share diluted earnings to be between $0.85 and $0.91. The per share estimates assume an increase in average diluted shares outstanding from approximately 42.2 million at fiscal 2014 year end to 42.4 million at fiscal 2015 year end. The revenues and earnings guidance provided in this press release is from expected internal growth and does not include the impact of any acquisitions the Company might complete during fiscal 2015.
VIVO: 16.15 (-0.04)

3 Value Stocks to Consider for Your Portfolio
Sean Williams, The Motley Fool - Motley Fool - Tue Aug 26, 12:32PM CDT
Just as we often examine companies that may be rising past their fair values, we can also find companies trading at what may be bargain prices. While many investors would rather have nothing to do with stocks wallowing at 52-week lows, I think it...
VIVO: 16.15 (-0.04), RIG: 25.77 (-0.28), BAGL: 20.23 (-0.01)

Meridian Bioscience partners with University of Tennessee Research Foundation to develop electrokinetic sensor technology
M2 - Thu Aug 07, 6:58AM CDT
Life science company Meridian Bioscience (NasdaqGS:VIVO) announced on Wednesday that it executed a technology and commercial license agreement for the development of an innovative new technology that has the potential to result in a low cost, point-of-care detection platform capable of detecting proteins, small molecules, bacteria and viruses in minutes.
VIVO: 16.15 (-0.04)

Meridian Bioscience and the University of Tennessee Research Foundation Enter into a License Agreement for Electrokinetic Sensor Technology
Business Wire - Wed Aug 06, 8:00AM CDT
Meridian Bioscience, Inc. (NASDAQ: VIVO), today announced that it has entered into a technology and commercial license agreement with the University of Tennessee Research Foundation (UTRF) for the development of an innovative new technology that has the potential to result in a low cost, point-of-care detection platform capable of detecting proteins, small molecules, bacteria and viruses in minutes.
VIVO: 16.15 (-0.04)

Meridian Bioscience Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 12:58PM CDT
For fiscal 2014, Meridian Bioscience, Inc. (VIVO) expects earnings per share between 85 and 90 cents while revenues are expected in the range of $190 to $195 million.
BSX: 13.39 (+0.03), VIVO: 16.15 (-0.04), ALR: 40.03 (+0.03), OSUR: 8.80 (+0.03)

Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance
Business Wire - Thu Jul 24, 7:15AM CDT
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
VIVO: 16.15 (-0.04)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 220

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 263

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 82

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 118

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Common Tiger Bets $499 on Better Outdoor Seating Design

Updated Category News Views 26

A chair that refuses to slump into the camping aisle is Common Tiger's whole argument, and frankly it is a smarter argument than another flimsy fold-up contraption pretending comfort is optional. The Los Angeles, female-founded and women-owned brand is launching with one product, The Daymaker, after four years of development. That is a long runway for a debut chair, which...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 8

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 194

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 26

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 86

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
Lotte's Songdo Plant 1 Puts 120,000 Liters on Deck

Updated Category News Views 68

A 120,000-liter biomanufacturing plant is not a ribbon-cutting trinket; it is a serious industrial bet that has to earn its keep one qualified batch at a time. LOTTE Biologics has completed Plant 1 at its Songdo Bio Campus in Incheon, South Korea, giving the company a sizable new production base as it tries to become a more consequential player in the global CDMO...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Baker International Enhances Pavement Management Strategies

Updated Category News Views 313

Michael Baker International Teams Up with CVAG Michael Baker International, a well-known leader in engineering and consulting services, has recently been selected by the Coachella Valley Association of Governments (CVAG) for an important project focused on improving the area's pavement condition assessments. This partnership marks a significant step toward enhancing the...

Continue Reading
Fidus Investment Corporation Announces $100 Million Note Offering

Updated Category News Views 307

Fidus Investment Corporation's Recent Offering Announcement Fidus Investment Corporation (NASDAQ: FDUS) has recently made a significant announcement regarding its financial strategy. The company has priced an underwritten public offering of 6.750% notes, with an aggregate principal amount of $100 million, due in 2030. This initiative is aimed at strengthening its capital...

Continue Reading
WillScot Strengthens Board with New Appointment to Drive Growth

Updated Category News Views 49

WillScot Appoints Worthing Jackman to Board of Directors WillScot Holdings Corporation (NASDAQ: WSC), a leader in flexible space and storage solutions, has made a strategic move by appointing Worthing Jackman to its Board of Directors. This significant addition is aimed at reinforcing the company's growth strategy and bolstering its financial and operational performance....

Continue Reading
National Press Club Reacts to Pentagon's New Media Restrictions

Updated Category News Views 510

Concerns Regarding Pentagon's Media Access Restrictions Recently, the National Press Club leadership voiced significant concerns about new media restrictions imposed by the Pentagon. A statement from the club highlighted that these restrictions threaten transparency and reduce public access to information critical for accountability. Impact on Journalistic Integrity...

Continue Reading
Dogecoin and Shiba Inu Surge: A New Era for Meme Coins

Updated Category News Views 100

A Look at the Recent Surge in Dogecoin and Shiba Inu Recently, Dogecoin and Shiba Inu, both leaders in the meme coin market, have experienced notable price spikes. Dogecoin's value has risen by 4.5%, while Shiba Inu has jumped an impressive 8%. These increases follow important economic news about a cut in interest rates, which is bringing renewed optimism among crypto...

Continue Reading